Gene Mutation Found for Aggressive Form of Pancreatic Cancer
By LabMedica International staff writers Posted on 04 Jun 2014 |

Image: The RotorGene RG-3000 thermal cycler system (Photo courtesy of Corbett Research).

Image: Photomicrograph of pancreatic adenosquamous carcinoma (Photo courtesy of Ralph H Hruban and Noriyoshi Fukushima).
A mutated gene common to adenosquamous carcinoma tumors has been discovered and is the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer.
Pancreatic adenosquamous carcinoma (ASC) is an enigmatic and aggressive tumor that has a worse prognosis and higher metastatic potential than its adenocarcinoma counterpart. There has been little progress in understanding pancreatic ASC, as no mutations unique to this class of pancreatic tumors have been identified.
Scientists at the University of California, San Diego School of Medicine (La Jolla, CA, USA) and an international team evaluated a set of tumors and corresponding normal tissues from 23 patients with ASC of the pancreas, as well as tumors from 24 patients with ductal adenocarcinoma, three patients with solid pseudopapillary neoplasm, two patients with neuroendocrine carcinoma and 21 patients with lung squamous cell carcinoma. Of the 23 ASC patient specimens, there were 19 formalin-fixed, paraffin-embedded (FFPE) tissue sections available. The other four ASC patient specimens were frozen immediately after collection.
Genomic DNA from the frozen samples was extracted using the DNeasy Blood & Tissue Kit (Qiagen; Valencia, CA, USA) and genomic DNA from the FFPE samples was extracted using Qiagen’s QIAamp DNA FFPE Tissue Kit. Quantitative real-time reverse-transcription PCR (RT-qPCR) analysis was performed using the relative quantification method in a RotorGene RG-3000 thermal cycler system (Corbett Research; Mortlake, NSW, Australia).
The investigators found that that ASC pancreatic tumors have somatic or non-heritable mutations in the Up-frameshift 1 (UPF1) gene, which is involved in a highly conserved RNA degradation pathway called nonsense-mediated RNA decay or NMD. It is the first known example of genetic alterations in an NMD gene in human tumors. NMD has two major roles. First, it is a quality control mechanism used by cells to eliminate faulty messenger RNA (mRNA). Second, it degrades a specific group of normal mRNAs, including those encoding proteins promoting cell growth, cell migration and cell survival.
Miles F. Wilkinson, PhD, co-senior author, said, “There has been little progress in understanding pancreatic ASC since these aggressive tumors were first described more than a century ago. One problem has been identifying mutations unique to this class of tumors.” The study was published on May 25, 2014, in the journal Nature Medicine.
Related Links:
University of California, San Diego School of Medicine
Qiagen
Corbett Research
Pancreatic adenosquamous carcinoma (ASC) is an enigmatic and aggressive tumor that has a worse prognosis and higher metastatic potential than its adenocarcinoma counterpart. There has been little progress in understanding pancreatic ASC, as no mutations unique to this class of pancreatic tumors have been identified.
Scientists at the University of California, San Diego School of Medicine (La Jolla, CA, USA) and an international team evaluated a set of tumors and corresponding normal tissues from 23 patients with ASC of the pancreas, as well as tumors from 24 patients with ductal adenocarcinoma, three patients with solid pseudopapillary neoplasm, two patients with neuroendocrine carcinoma and 21 patients with lung squamous cell carcinoma. Of the 23 ASC patient specimens, there were 19 formalin-fixed, paraffin-embedded (FFPE) tissue sections available. The other four ASC patient specimens were frozen immediately after collection.
Genomic DNA from the frozen samples was extracted using the DNeasy Blood & Tissue Kit (Qiagen; Valencia, CA, USA) and genomic DNA from the FFPE samples was extracted using Qiagen’s QIAamp DNA FFPE Tissue Kit. Quantitative real-time reverse-transcription PCR (RT-qPCR) analysis was performed using the relative quantification method in a RotorGene RG-3000 thermal cycler system (Corbett Research; Mortlake, NSW, Australia).
The investigators found that that ASC pancreatic tumors have somatic or non-heritable mutations in the Up-frameshift 1 (UPF1) gene, which is involved in a highly conserved RNA degradation pathway called nonsense-mediated RNA decay or NMD. It is the first known example of genetic alterations in an NMD gene in human tumors. NMD has two major roles. First, it is a quality control mechanism used by cells to eliminate faulty messenger RNA (mRNA). Second, it degrades a specific group of normal mRNAs, including those encoding proteins promoting cell growth, cell migration and cell survival.
Miles F. Wilkinson, PhD, co-senior author, said, “There has been little progress in understanding pancreatic ASC since these aggressive tumors were first described more than a century ago. One problem has been identifying mutations unique to this class of tumors.” The study was published on May 25, 2014, in the journal Nature Medicine.
Related Links:
University of California, San Diego School of Medicine
Qiagen
Corbett Research
Latest Molecular Diagnostics News
- New DNA Methylation-Based Method Predicts Cancer Progression
- Urine Test Could Predict Outcome of Cartilage Transplant Surgery
- 2-Hour Cancer Blood Test to Transform Tumor Detection
- Ultrasensitive Test Could Identify Earliest Molecular Signs of Metastatic Relapse in Breast Cancer Patients
- Automated High Throughput Immunoassay Test to Advance Neurodegenerative Clinical Research
- Blood Test Could Detect Proteins Linked to Alzheimer's Disease and Memory Loss
- Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear
- First-of-Its-Kind Blood Test Detects Over 50 Cancer Types
- Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk
- Single Cell RNA Sequencing Could Enable Non-Invasive Blood Disorder Diagnosis
- Blood Test Identifies HPV-Associated Head and Neck Cancers 10 Years Before Symptoms
- Giant DNA Elements Discovered in Mouth Could Impact Oral Health
- Simple Blood Test Spots Disease Through Metabolic Distortion
- Simple Blood Test Could Streamline Early Alzheimer's Detection
- Unique Microbial Fingerprint to Improve Diagnosis of Colorectal Cancer
- ELISA-Based Test Uses Gynecologic Fluids to Detect Endometrial Cancer
Channels
Clinical Chemistry
view channel
Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
Ovarian cancer is considered one of the deadliest cancers, in part because it rarely shows clear symptoms in its early stages, and diagnosis is often complex. Current approaches make it difficult to accurately... Read more
Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read moreHematology
view channel
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read moreImmunology
view channel
Novel Tool Uses Deep Learning for Precision Cancer Therapy
Nearly 50 new cancer therapies are approved each year, but selecting the right one for patients with highly individual tumor characteristics remains a major challenge. Physicians struggle to navigate the... Read more
Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients
Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read moreMicrobiology
view channel
Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Sepsis arises from infection and immune dysregulation, with neutrophils playing a central role in its progression. However, current clinical tools are unable to both isolate these cells and assess their... Read more
New Diagnostic Method Confirms Sepsis Infections Earlier
Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. Each hour of delayed treatment in septic shock reduces patient survival... Read more
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
ESR Testing Breakthrough Extends Blood Sample Stability from 4 to 28 Hours
Erythrocyte sedimentation rate (ESR) is one of the most widely ordered blood tests worldwide, helping clinicians detect and monitor infections, autoimmune conditions, cancers, and other diseases.... Read more
Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma
Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Clinicopathologic Study Supports Exclusion of Cervical Serous Carcinoma from WHO Classification
High-grade serous carcinoma is a rare diagnosis in cervical biopsies and can be difficult to distinguish from other tumor types. Cervical serous carcinoma is no longer recognized as a primary cervical... Read moreTechnology
view channel
Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine
The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Rapid Diagnostic Technology Utilizes Breath Samples to Detect Lower Respiratory Tract Infections
Respiratory tract infections (LRTIs) are leading causes of illness and death worldwide, particularly among vulnerable populations such as the elderly, young children, and those with compromised immune systems.... Read moreIndustry
view channel
VedaBio Partners With Mammoth Biosciences to Expand CRISPR-Based Diagnostic Technologies
VedaBio (San Diego, CA, USA) has entered into a non-exclusive license agreement with Mammoth Biosciences (Brisbane, CA, USA) for the use of select CRISPR-based technologies in diagnostic applications.... Read more